<sup>18</sup>F-ML-10监测多柔比星诱发心脏毒性的可行性探讨

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (942 KB) RICH HTML
输出: BibTeX | EndNote (RIS)

摘要目的探讨放射性核素凋亡显像剂¹⁸F-ML-10无创监测多柔比星诱发心脏毒性的可行性。方法 36只KM小鼠随机分为对照组、低剂量(15 mg/kg)多柔比星模型组和高剂量(20 mg/kg)多柔比星模型组,每组12只。对照组腹腔注射生理盐水,多柔比星模型组腹腔注射一定剂量的多柔比星,48 h后进行小动物超声检测左室射血分数 (left ventricular ejection fraction, LVEF),以及放射性显像剂¹⁸F-ML-10与¹⁸F-FDG在小鼠体内的生物分布并测定每克组织放射性摄取值(%ID/g),处死的小鼠取出心脏进行caspase 3免疫组化检测心肌细胞的凋亡情况。结果超声结果显示低剂量组[LVEF=(59.49±5.32)%]与高剂量组LVEF=(52.41±6.47)%小鼠左室射血分数明显低于对照组LVEF=(70.58±5.06)%,¹⁸F-FDG在低剂量组(%ID/g=21.67±3.69)与高剂量组(%ID/g=15.58±1.92)的摄取也明显低于对照组(%ID/g=36.18±3.65),而凋亡显像剂¹⁸F-ML-10在低剂量组(%ID/g=0.50±0.11)与高剂量组(%ID/g=1.100.55)的摄取明显明显高于对照组(%ID/g=0.02±0.02),差异均有统计学意义(P<0.05),caspase 3免疫组化显示模型组心肌细胞发生明显凋亡,与¹⁸F-ML-10在心脏的摄取相一致。结论心肌细胞的凋亡是多柔比星诱导心脏毒性的重要途径,特异性凋亡显像剂¹⁸F-ML-10用于多柔比星诱发心肌细胞凋亡的毒性监测具有较好的应用前景。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	黄世明
	陈薇
	张锦明
	马永强
	岳建兰
	李彦峰
	林志春

关键词 ：多柔比星, 心脏毒性, 凋亡, ¹⁸F-ML-10

Abstract：Objective To investigate the feasibility of noninvasive monitoring of doxorubicin-induced cardiotoxicity by radionuclide apoptosis imaging agent ¹⁸F-ML-10.Methods Thirty-six KM mice were randomly and equally divided into control group, low dose (15 mg / kg) model group and high dose (20 mg/kg) model group. The mice in control group were injected with normal saline. Doxorubicin was injected into model group at some dose. After 48 hours, mice were subjected to cardiac ultrasonography and the biodistribution of ¹⁸F-FDG and ¹⁸F-ML-10 was determined with gamma counting. The mice were sacrificed to remove the heart for caspase 3 immunohistochemical detection of myocardial cell apoptosis.Results The left ventricular ejection fraction was significantly lower in low dose group (LVEF=59.49±5.32%) and high dose group (LVEF=52.41±6.47%) than that in control group (LVEF=70.58±5.06%), but the uptake of ¹⁸F-FDG in low dose group (%ID/g=0.50±0.11) and high dose group (%ID/g=15.58±1.92) was significantly lower than that in control group (%ID/g=36.18±3.65).The uptake of apoptotic imaging agent ¹⁸F-ML-10 in low dose group (%ID/g=0.50±0.11) and high dose group(%ID/g=1.10±0.55)was significantly higher than that in control group (%ID/g=0.02±0.02) (P<0.05). Caspase 3 immunohistochemistry showed obvious apoptosis of myocardial cells in model group, which was consistent with the uptake of ¹⁸F-ML-10 in the heart.Conclusions Apoptosis is an important pathway for doxorubicin-induced cardiotoxicity. ¹⁸F-ML-10 may contribute to the detection of doxorubicin-induced myocardial apoptosis.

Key words： doxorubicin cardiotoxicity apoptosis ¹⁸F-ML-10

收稿日期: 2016-08-11

ZTFLH:

R817

基金资助:天津市自然科学基金资助项目(13JCYBJC22000),武警后勤学院附属医院种子基金资助项目(FYQ201601)

通讯作者: 林志春,E-mail: zhichunlin@163.com.

作者简介: 黄世明,在读硕士研究生。

引用本文:

黄世明, 陈薇, 张锦明, 马永强, 岳建兰, 李彦峰, 林志春. ¹⁸F-ML-10监测多柔比星诱发心脏毒性的可行性探讨[J]. 武警医学, 2017, 28(3): 227-231. HUANG Shiming, CHEN Wei, ZHANG Jinming, MA Yongqiang, YUE Jianlan, LI Yanfeng, and LIN Zhichun. Feasibility of using ¹⁸F-ML-10 to monitor cardiotoxicity induced by doxorubicin. Med. J. Chin. Peop. Armed Poli. Forc., 2017, 28(3): 227-231.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2017/V28/I3/227

[1]	Jean S R, Tulumello D V, Riganti C, et al. Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity[J]. ACS Chem Biol, 2015, 10(9):2007-2015.
[2]	王雅婧, 刘德权, 叶剑桥. 多西他赛与表柔比星联合或序贯化疗治疗局部晚期乳腺癌临床观察[J]. 武警医学, 2014, 25(09):921-923.
[3]	Yancy C W, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013, 62(16):e147-239.
[4]	Cao Y, Ruan Y, Shen T, et al. Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways[J]. Oxid Med Cell Longev, 2014, 2014:674219.
[5]	Hoglund J, Shirvan A, Antoni G, et al. 18F-ML-10, a PET tracer for apoptosis: first human study[J]. J Nucl Med, 2011, 52(5):720-725.
[6]	Oborski M J, Laymon C M, Lieberman F S, et al. First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy[J]. Brain Behav, 2014, 4(2):312-315.
[7]	Hyafil F, Tran-Dinh A, Burg S, et al. Detection of Apoptotic Cells in a Rabbit Model with Atherosclerosis-Like Lesions Using the Positron Emission Tomography Radiotracer [18F]ML-10[J]. Mol Imaging, 2015, 14:433-442.
[8]	Gardin J M, Siri F M, Kitsis R N, et al. Echocardiographic assessment of left ventricular mass and systolic function in mice[J]. Circ Res, 1995, 76(5):907-914.
[9]	Kalam K and Marwick T H. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis[J]. Eur J Cancer, 2013, 49(13):2900-2909.
[10]	Curigliano G, Cardinale D, Dent S, et al. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management[J]. CA Cancer J Clin, 2016, 66(4):309-325.
[11]	Dodos F, Halbsguth T, Erdmann E, et al. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults[J]. Clin Res Cardiol, 2008, 97(5):318-326.
[12]	Ewer M S ,Lenihan D J. Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?[J]. J Clin Oncol, 2008, 26(8):1201-1203.
[13]	Su H, Gorodny N, Gomez L F, et al. Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity[J]. Circ Cardiovasc Imaging, 2015, 8(2):e001952.
[14]	Panjrath G S, Patel V, Valdiviezo C I, et al. Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model[J]. J Am Coll Cardiol, 2007, 49(25):2457-2464.
[15]	Allen A M, Ben-Ami M, Reshef A, et al. Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with (1)(8)F-ML-10[J]. Eur J Nucl Med Mol Imaging, 2012, 39(9):1400-1408.